RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eurobio Scientific Stock

Eurobio Scientific Stocks 2024

Eurobio Scientific Stocks

11.22 M

Ticker

ALERS.PA

ISIN

FR0013240934

WKN

A2DVTN

In 2024, Eurobio Scientific had 11.22 M outstanding stocks, a 0% change from the 11.22 M stocks in the previous year.

The Eurobio Scientific Stocks history

YEARNUMBER OF STOCKS (undefined EUR)
2026e11.22
2025e11.22
2024e11.22
202311.22
202210.26
202110.88
202011.25
201911.26
20189.8
20178.77
20163.91
20153.55
20143.1
20132.85
20121.8
20111.68
20101.65
20091.41
20081.34
20071.28
20061.17
20050.98
20040.96

Eurobio Scientific shares outstanding

The number of shares was Eurobio Scientific in 2023 — This indicates how many shares 11.217 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eurobio Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eurobio Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eurobio Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eurobio Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eurobio Scientific Aktienanalyse

What does Eurobio Scientific do?

Eurobio Scientific SA is a French company specializing in the development and marketing of diagnostic and research products in the field of biology. It was founded in 2007 as a spin-off from the Pierre and Marie Curie University and is headquartered in Paris. Since 2017, the company has been listed on Euronext Growth in Paris. The company's business model is based on clear divisional structure with various product lines, including clinical diagnostics, research diagnostics, blood bank diagnostics, food analysis, and animal health research. Eurobio Scientific SA operates in over 60 countries and has a strong presence in Europe and Asia. Its notable products include the COVID-19 antibody test ELISA, a rapid COVID-19 test based on immuno-chromatography, and an All-In-One PCR test system for detecting COVID-19. This system allows for the rapid identification of the virus through a single reaction tube. Overall, Eurobio Scientific SA is an innovative company committed to constant product development and improvement, and its diverse product portfolio and international presence highlight its strength and position as an emerging player in the field of diagnostic and research products. Eurobio Scientific ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Eurobio Scientific's Shares Outstanding

Eurobio Scientific's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Eurobio Scientific’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Eurobio Scientific’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Eurobio Scientific’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Eurobio Scientific stock

How many stocks are there of Eurobio Scientific?

The current number of stocks of Eurobio Scientific is 11.22 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Eurobio Scientific are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Eurobio Scientific evolved in recent years?

The number of shares of Eurobio Scientific has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Eurobio Scientific as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Eurobio Scientific?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Eurobio Scientific pay?

Over the past 12 months, Eurobio Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eurobio Scientific is expected to pay a dividend of 0 EUR.

What is the dividend yield of Eurobio Scientific?

The current dividend yield of Eurobio Scientific is .

When does Eurobio Scientific pay dividends?

Eurobio Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eurobio Scientific?

Eurobio Scientific paid dividends every year for the past 0 years.

What is the dividend of Eurobio Scientific?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eurobio Scientific located?

Eurobio Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eurobio Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eurobio Scientific from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Eurobio Scientific pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Eurobio Scientific in the year 2023?

In the year 2023, Eurobio Scientific distributed 0 EUR as dividends.

In which currency does Eurobio Scientific pay out the dividend?

The dividends of Eurobio Scientific are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eurobio Scientific

Our stock analysis for Eurobio Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eurobio Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.